MTOR and breast cancer: It can activate the mTOR pathway in BC, while increased expression of TGF-β receptors is associated with the activation of suppressor of mothers against decapentaplegic (SMAD) proteins, leading to high-grade and muscle-invasive bladder cancer (MIBC) (Pathway I, Figure 2) [54].